A post on Facebook claims that a new cure for Acquired immunodeficiency syndrome (AIDS) has been discovered and will cost $40 ...
Gilead plans to begin Phase 3 testing soon for a drug it believes could prevent HIV infection with a single shot every year ...
Numbers put us in the know. We saw that with COVID-19, and now again, with Rwanda snuffing out the Marburg virus outbreak in ...
The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.
This drug helps manage infections and prevent AIDS, but claims it’s a ‘cure’ are not supported
"Currently, there is no therapeutic cure for HIV," Sheryl Zwerski, who holds a Doctor of Nursing Practice and directs the Prevention Sciences Program at the National Institute of Allergy and ...
Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.
Gilead Sciences (GILD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Courtney ...
Graham Parry, an analyst from Bank of America Securities, maintained the Sell rating on GlaxoSmithKline (GSK – Research Report). The associated ...
The incidence of HIV is lower with receipt of twice-yearly subcutaneous lenacapavir compared with daily oral emtricitabine-tenofovir disoproxil fumarate.
Advertisement Those interested in taking part in clinical trials for HIV prevention – including the REV UP clinical trial – can contact Sherri Karas Certo by calling or texting 412-818-4942 or ...
A drug used to treat HIV that has also shown promise in preventing infections is not a cure for those already infected, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback